1. Home
  2. PRTS vs NXTC Comparison

PRTS vs NXTC Comparison

Compare PRTS & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarParts.com Inc.

PRTS

CarParts.com Inc.

HOLD

Current Price

$0.79

Market Cap

44.4M

ML Signal

HOLD

Logo NextCure Inc.

NXTC

NextCure Inc.

HOLD

Current Price

$12.45

Market Cap

44.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTS
NXTC
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
44.6M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
PRTS
NXTC
Price
$0.79
$12.45
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$0.50
$23.00
AVG Volume (30 Days)
775.3K
24.1K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$22,378,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.23
52 Week High
$1.36
$15.74

Technical Indicators

Market Signals
Indicator
PRTS
NXTC
Relative Strength Index (RSI) 62.51 46.44
Support Level $0.78 $10.73
Resistance Level $0.92 $13.47
Average True Range (ATR) 0.06 1.10
MACD -0.00 -0.08
Stochastic Oscillator 55.21 42.72

Price Performance

Historical Comparison
PRTS
NXTC

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: